BIT’s 13thAnnual World
Cancer Congress -2023
July 17-19, 2023 | Lisbon, Portugal
Preliminary Program
Stream 1: Main Conference |
|
Part 1: Opening Ceremony |
Part 2: Keynote Forum |
Stream 2: Parallel Forums |
|
Track 1: Basic Research in Oncology |
|
Track 1-1: Molecular Carcinogenesis, Oncogenes and Tumor Suppressors in Cancer |
Track 1-2: Cancer Genetics, Genomics and Epigenetics |
Track 1-3: Cellular and Molecular Biology of Cancer |
Track 1-4: MicroRNAs and Long Noncoding RNAs in Cancers |
Track 1-5: Novel Signal Transduction Pathways in Cancer Research |
Track 1-6: Cancer Metabolism and Metabolic Pathways |
Track 1-7: Tumor Microenvironment |
Track 1-8: Cancer Bioinformatics and Systems Biology |
Track 2: Frontiers in Cancer Prevention and Diagnostics |
|
Track 2-1: Cancer Prognostic Biomarkers and Predictive Factors |
Track 2-2: Cancer Epidemiology, Risk Assessment and Control |
Track 2-3: Current and Emerging Cancer Diagnostic Technologies and Tests |
Track 2-4: Cancer Molecular Imaging and Nuclear Oncology |
Track 2-5: Liquid Biopsies: Cell-Free DNA and Circulating Tumor Cells |
Track 2-6: Artificial Intelligence in Cancer Diagnostics |
Track 2-7: Lab on a Chip and Microarrays |
Track 2-8: Molecular Pathology/Cytopathology Approaches, Tissue and Cell-Based Cancer Diagnostics |
Track 3: Novel Approaches to Cancer Therapeutics |
|
Track 3-1: Radiotherapy |
Track 3-2: Chemotherapy and Photodynamic Therapy |
Track 3-3: Robotic & Surgical Therapy |
Track 3-4: Immunotherapy |
Track 3-5: Cancer Precision Medicine and Personalized Therapy |
Track 3-6: Advanced Targeted Cancer Therapies |
Track 3-7: Cancer Biotherapies |
Track 3-8: Combination Therapy, Complementary and Alternative Medicine |
Track 4: Latest Anticancer Drug Discovery |
|
Track 4-1: Anticancer Drug Discovery, Design and Optimization |
Track 4-2: Anticancer Drug Delivery |
Track 4-3: Anticancer Drug Candidates Toxicity and Efficacy |
Track 4-4: Anticancer Drugs from TCM and Natural Products |
Track 5: Medical Research on Tumors |
|
Track 5-1: Head, Neck, Brain Cancers and CNS Tumors |
Track 5-2: Lung Cancer/Other Thoracic Cancers |
Track 5-3: Breast Cancer |
Track 5-4: Gynecologic Cancer |
Track 5-5: Liver, Cholecyst and Pancreatic Cancer |
Track 5-6: Gastrointestinal Cancer |
Track 5-7: Genitourinary Cancer |
Track 5-8: Hematologic Malignancies |
Track 5-9: Melanoma/Skin Cancers |
Track 5-10: Sarcoma |
Track 5-11: Pediatric Oncology |
|
Track 6: Oncology Nursing & Palliative Care |
|
Track 6-1: Cancer Rehabilitation, Cancer Nursing and Care |
Track 6-2: Pain Management and Clinical Complications |
Track 6-3: Psycho-Oncology, Patient and Survivor Care |
Track 6-4: Palliative & Critical care |
Stream 3: Posters and Exhibition |
|
Zone 1: Posters |
Zone 2: New Products and Technologies Expo |
Stream 4: Social and Cultural Activities |
|
Activity 1: Welcome Banquet and Art Performance |
Activity 2: Industrial Sponsored Cocktail Party |
Activity 3: Field Trip to Industry Park/Universities |
Activity 4: Local Impression Tech-Tour |
World High Technology Society
Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France
Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA
Contact Us: vicky-wcc@eventcomittee.com
Copyright © 2008-2023 BIT Congress